NASDAQ: SILO - Silo Pharma, Inc.

半年間の収益性: -12.5%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Silo Pharma, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Silo Pharma, Inc.

Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. The company's developing solutions to address various underserved conditions. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders.

さらに詳しく
The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2014-05-13
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://silopharma.com
Цена ао 1.36
1日あたりの価格変動: -0.0095% (1.0501)
週ごとの価格変動: -2.78% (1.08)
月ごとの料金変更: -24.46% (1.39)
3ヶ月間の価格変動: -40% (1.75)
半年間の価格変動: -12.5% (1.2)
年間の価格変動: -46.43% (1.96)
3年間の価格推移: +375.11% (0.221)
5年間の価格推移: +13 025% (0.008)
年初からの価格変動: +27.74% (0.822)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 68.34 1
P/BV 0.7978 9
P/E 0 0
EV/EBITDA -0.364 0
合計: 4.63

効率

名前 意味 学年
ROA, % -47.77 0
ROE, % -59.91 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 9.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 75.86 8
収益性 Ebitda, % 327.45 10
収益性 EPS, % -46.12 0
合計: 7.6
さらに詳しく

機関 音量 共有, %
Financial Advocates Investment Management 62807 0.06
UBS Group AG 32843 0.03
Vanguard Group Inc 16334 0.02
Geode Capital Management, LLC 16179 0.02
TWO SIGMA SECURITIES, LLC 12788 0.01
State Street Corporation 12500 0.01
Tower Research Capital LLC (TRC) 7007 0.01
Westside Investment Management, Inc. 94 0
FWL INVESTMENT MANAGEMENT, LLC 80 0
Wells Fargo & Company 20 0



スーパーバイザー 役職 支払い 生年
Mr. Eric Weisblum Chairman, President & CEO 569.01k 1970 (55 年)
Mr. Daniel E. Ryweck Chief Financial Officer 62.69k 1965 (60 年)
Dr. James S. Kuo M.B.A., M.D. Vice President of Research & Development N/A 1965 (60 年)

住所: United States, Englewood Cliffs. NJ, 560 Sylvan Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://silopharma.com